Quantcast
Last updated on April 24, 2014 at 21:24 EDT

General Anxiety Disorder Global Clinical Trials Review, H2, 2013

October 24, 2013

Reportbuyer.com just published a new market research report: General Anxiety Disorder Global Clinical Trials Review, H2, 2013.

London (PRWEB) October 24, 2013

General Anxiety Disorder Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “General Anxiety Disorder Global Clinical Trials Review, H2, 2013" provides data on the General Anxiety Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on General Anxiety Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating General Anxiety Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

General Anxiety Disorder 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by BRIC Nations 17

Clinical Trials by G7 Nations 18

Clinical Trials in G7 Nations by Trial Status 19

Clinical Trials by E7 Nations 20

Clinical Trials in E7 Nations by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Unaccomplished Trials of General Anxiety Disorder 25

Subjects Recruited Over a Period of Time 27

Prominent Sponsors 28

Top Companies Participating in General Anxiety Disorder Therapeutics Clinical Trials 30

Prominent Drug Comparison 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Pfizer Inc. 33

Clinical Trial Overview of Pfizer Inc. 33

Sanofi 35

Clinical Trial Overview of Sanofi 35

Eli Lilly and Company 36

Clinical Trial Overview of Eli Lilly and Company 36

Cephalon, Inc. 37

Clinical Trial Overview of Cephalon, Inc. 37

H. Lundbeck A/S 38

Clinical Trial Overview of H. Lundbeck A/S 38

Forest Laboratories, Inc. 39

Clinical Trial Overview of Forest Laboratories, Inc. 39

Merck & Co., Inc. 40

Clinical Trial Overview of Merck & Co., Inc. 40

Takeda Global Research and Development Center, Inc 41

Clinical Trial Overview of Takeda Global Research and Development Center, Inc 41

F. Hoffmann-La Roche Ltd. 42

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42

AstraZeneca PLC 43

Clinical Trial Overview of AstraZeneca PLC 43

Bionomics Limited 44

Clinical Trial Overview of Bionomics Limited 44

Mylan Pharmaceuticals Inc. 45

Clinical Trial Overview of Mylan Pharmaceuticals Inc. 45

Fabre-Kramer Pharmaceuticals, Inc. 46

Clinical Trial Overview of Fabre-Kramer Pharmaceuticals, Inc. 46

Dr. Willmar Schwabe GmbH & Co. KG 47

Clinical Trial Overview of Dr. Willmar Schwabe GmbH & Co. KG 47

Torrent Pharmaceuticals Limited 48

Clinical Trial Overview of Torrent Pharmaceuticals Limited 48

Par Pharmaceutical Companies, Inc. 49

Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 49

Mitsubishi Tanabe Pharma Corporation 50

Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 50

Shire Plc 51

Clinical Trial Overview of Shire Plc 51

Sun Pharmaceutical Industries Limited 52

Clinical Trial Overview of Sun Pharmaceutical Industries Limited 52

Teva Pharmaceutical Industries Limited 53

Clinical Trial Overview of Teva Pharmaceutical Industries Limited 53

Clinical Trial Overview of Top Institutes / Government 54

National Institute of Mental Health 54

Clinical Trial Overview of National Institute of Mental Health 54

University of California, San Diego 55

Clinical Trial Overview of University of California, San Diego 55

The University of South Florida 56

Clinical Trial Overview of The University of South Florida 56

Institut de Recherches Internationales Servier 57

Clinical Trial Overview of Institut de Recherches Internationales Servier 57

Massachusetts General Hospital 58

Clinical Trial Overview of Massachusetts General Hospital 58

Baylor College of Medicine 59

Clinical Trial Overview of Baylor College of Medicine 59

University of Pennsylvania 60

Clinical Trial Overview of University of Pennsylvania 60

University of Pittsburgh 61

Clinical Trial Overview of University of Pittsburgh 61

The University of New South Wales 62

Clinical Trial Overview of The University of New South Wales 62

Duke University 63

Clinical Trial Overview of Duke University 63

Karolinska Institutet 64

Clinical Trial Overview of Karolinska Institutet 64

University of California, Los Angeles 65

Clinical Trial Overview of University of California, Los Angeles 65

University of Bristol 66

Clinical Trial Overview of University of Bristol 66

University Hospital, Linkoeping 67

Clinical Trial Overview of University Hospital, Linkoeping 67

Golestan University of Medical Sciences 68

Clinical Trial Overview of Golestan University of Medical Sciences 68

Creighton University 69

Clinical Trial Overview of Creighton University 69

Tabriz University 70

Clinical Trial Overview of Tabriz University 70

Haukeland University Hospital 71

Clinical Trial Overview of Haukeland University Hospital 71

University of Massachusetts 72

Clinical Trial Overview of University of Massachusetts 72

National Taiwan University Hospital 73

Clinical Trial Overview of National Taiwan University Hospital 73

Five Key Clinical Profiles 74

Appendix 145

Abbreviations 145

Definitions 145

Research Methodology 146

Secondary Research 146

About GlobalData 147

Contact Us 147

Disclaimer 147

Source 148

1.1 List of Tables

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11

General Anxiety Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12

General Anxiety Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13

General Anxiety Disorder Therapeutics Clinical Trials, North America, Top Countries, 2013* 14

General Anxiety Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15

General Anxiety Disorder Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16

General Anxiety Disorder Therapeutics Clinical Trials, BRIC Countries, 2013* 17

General Anxiety Disorder Therapeutics Clinical Trials, G7 Countries, 2013* 18

General Anxiety Disorder Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19

General Anxiety Disorder Therapeutics Clinical Trials, E7 Countries, 2013* 20

General Anxiety Disorder Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24

General Anxiety Disorder Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25

General Anxiety Disorder Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26

General Anxiety Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27

General Anxiety Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29

General Anxiety Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31

General Anxiety Disorder Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 33

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 35

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 36

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2013* 37

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 38

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 39

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 40

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2013* 41

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 42

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 43

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Bionomics Limited, 2013* 44

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Pharmaceuticals Inc., 2013* 45

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Fabre-Kramer Pharmaceuticals, Inc., 2013* 46

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe GmbH & Co. KG, 2013* 47

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Torrent Pharmaceuticals Limited, 2013* 48

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Par Pharmaceutical Companies, Inc., 2013* 49

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2013* 50

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2013* 51

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2013* 52

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 53

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2013* 54

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 55

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of South Florida, 2013* 56

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2013* 57

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 58

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 59

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 60

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 61

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2013* 62

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 63

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 64

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 65

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bristol, 2013* 66

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Linkoeping, 2013* 67

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Golestan University of Medical Sciences, 2013* 68

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2013* 69

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University, 2013* 70

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2013* 71

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 72

General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 73

List of Figures

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11

General Anxiety Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12

General Anxiety Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13

General Anxiety Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14

General Anxiety Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15

General Anxiety Disorder Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16

General Anxiety Disorder Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17

General Anxiety Disorder Therapeutics Clinical Trials, G7 Countries (%), 2013* 18

General Anxiety Disorder Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19

General Anxiety Disorder Therapeutics Clinical Trials, E7 Countries (%), 2013* 20

General Anxiety Disorder Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24

General Anxiety Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27

General Anxiety Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28

General Anxiety Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30

General Anxiety Disorder Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32

GlobalData Methodology 146

Read the full report:

General Anxiety Disorder Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/diseases/general_anxiety_disorder_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11266280.htm


Source: prweb